Your browser doesn't support javascript.
loading
Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma.
Tao, Haisu; Zhang, Yuxin; Li, Jiang; Liu, Junjie; Yuan, Tong; Wang, Wenqiang; Liang, Huifang; Zhang, Erlei; Huang, Zhiyong.
Afiliação
  • Tao H; Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang Y; Hepatic Surgery Center, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Li J; Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Wuhan, China.
  • Liu J; Hepatic Surgery Center, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Yuan T; Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Wuhan, China.
  • Wang W; The First Affiliated Hospital, College of Medicine, Shihezi University, Shihezi, Xinjiang, China.
  • Liang H; NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, Beijing, China.
  • Zhang E; Hepatic Surgery Center, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Huang Z; Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Wuhan, China.
Mol Ther Oncolytics ; 28: 88-103, 2023 Mar 16.
Article em En | MEDLINE | ID: mdl-36699616

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos